end stage renal disease. Chronic kidney disease, stage 5
Conditions
Interventions
Intervention 1: Intervention group: 12 patients undergoing chronic hemodialysis who were matched with the control group based on age and gender were included in the study based on the inclusion criter
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: age >18 accessible during intervention period chronic hemodialysis at least for 6 months more than 2 sessions per week
Exclusion criteria
Exclusion criteria: major musculoskeletal disability leading to severe disability recent major surgery in less than 1 month uncontrolled diabetes in latest blood sampling
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiorespiratory fitness. Timepoint: at the beginning of the intervention and 6 month later. Method of measurement: 6 minute walk test.;Ventricular function. Timepoint: at the beginning of the intervention and 6 month later. Method of measurement: echocardiographic indices including LVEF,LVEDD,LVESD.;Muscular bulk. Timepoint: at the beginning of the intervention ,3 and 6 month later. Method of measurement: standard measurement of mid thigh.;Functional dyspnea. Timepoint: at the beginning of the intervention and 6 month later. Method of measurement: NYHA function classification.;Dyspnea during hemodialysis. Timepoint: at the beginning of the intervention and 3 , 6 month later. Method of measurement: borg 0-10 scale for dyspnea. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Pourmahdigholi
Shahid Beheshti University of Medical Sciences
Outcome results
None listed